share_log

Goldman Sachs Initiates Coverage On Olema Pharmaceuticals With Buy Rating, Announces Price Target of $24

Goldman Sachs Initiates Coverage On Olema Pharmaceuticals With Buy Rating, Announces Price Target of $24

高盛以買入評級啓動對Olema Pharmicals的報道,宣佈目標股價爲24美元
Moomoo 24/7 ·  04/02 07:09

Goldman Sachs analyst Richard Law initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces Price Target of $24.

高盛分析師理查德·勞以買入評級啓動了對奧萊瑪製藥(納斯達克股票代碼:OLMA)的報道,並宣佈目標股價爲24美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論